UTHR News and Press, United Therapeutics Corporation From 10/22/23

2023-10-22 12:25:39 ET Summary United Therapeutics Corporation is in a long-term uptrend, reaching a new all-time high, indicating strong demand for the stock. The company has a competitive advantage with a diverse and unique product portfolio, driving revenue and profit growth. ...

2023-10-20 16:32:32 ET More on Liquidia Key Upcoming Catalysts Could Finally Turn Liquidia Profitable Liquidia Corporation (LQDA) Q2 2023 Earnings Call Transcript Liquidia adds second indication for Yutrepia marketing application Liquidia falls as U.S. appeal...

2023-10-10 14:44:04 ET More on MannKind MannKind's Robust Patient Demand, Operational Efficiency To Drive Revenue Beyond Q2 2023 MannKind Corporation 2023 Q2 - Results - Earnings Call Presentation MannKind Corporation (MNKD) Q2 2023 Earnings Call Transcript S...

2023-10-05 22:21:27 ET Summary I argue that financial professionals should pay more attention to large-cap stocks outside the S&P 500, as they often offer missed opportunities for investors. The S&P 500 is not a purely passive index, as it is actively managed and has speci...

2023-10-03 17:46:09 ET More than 80 stocks were identified by Morgan Stanley as potentially having technical pressure due to tax loss selling. A Morgan Stanley U.S. Equity Strategy report, published on Monday, showed 81 stocks that could have performance pressures due to market selling ...

Second UHeart™ recipient recovering after a successful transplant UThymoKidney™ demonstrates normal function during a 61-day study Human xenotransplant clinical studies could begin in 2025 United Therapeutics Corporation (Nasdaq: UTHR ), a public benefi...

Report available at corporateresponsibility.unither.com United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation ( PBC ), today announced the release of its 2023 Corporate Responsibility and Public Benefit Report covering its 2022 progress toward its pub...

United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, announced today that James Edgemond , Chief Financial Officer and Treasurer, will provide an overview and update on the company’s business during a fireside chat session at the Morgan Stanley 21st Annual...

2023-08-17 05:12:48 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The events of the last few years have made biotech investing look easier than it is. But, investing in biotech is not for the faint of heart. Many of these undervalued biotech stocks ...

2023-08-03 17:41:54 ET Summary United Therapeutics Corporation (NASDAQ: UTHR) reported strong quarterly results, adding strength to its economic characteristics. The company's financial performance and cash flows indicate the potential for sustained high returns on operating capit...